Design Therapeutics, Inc. (DSGN)
10.68
-0.38
(-3.44%)
USD |
NASDAQ |
Oct 30, 16:00
10.66
-0.02
(-0.19%)
After-Hours: 20:00
Design Therapeutics Market Cap : 668.36M for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2026 | 668.36M |
| October 29, 2026 | 692.14M |
| October 28, 2026 | 693.39M |
| October 27, 2026 | 665.23M |
| October 26, 2026 | 647.08M |
| October 23, 2026 | 640.82M |
| October 22, 2026 | 656.47M |
| October 21, 2026 | 671.48M |
| October 20, 2026 | 694.64M |
| October 19, 2026 | 665.85M |
| October 16, 2026 | 645.20M |
| October 15, 2026 | 655.84M |
| October 14, 2026 | 608.90M |
| October 13, 2026 | 612.03M |
| October 12, 2026 | 682.75M |
| October 09, 2026 | 729.06M |
| October 08, 2026 | 719.05M |
| October 07, 2026 | 731.56M |
| October 06, 2026 | 749.08M |
| October 05, 2026 | 777.24M |
| October 02, 2026 | 772.24M |
| October 01, 2026 | 765.98M |
| September 30, 2026 | 786.63M |
| September 29, 2026 | 789.76M |
| September 28, 2026 | 773.49M |
| Date | Value |
|---|---|
| September 25, 2026 | 758.47M |
| September 24, 2026 | 765.98M |
| September 23, 2026 | 773.49M |
| September 22, 2026 | 823.55M |
| September 21, 2026 | 785.38M |
| September 18, 2026 | 765.98M |
| September 17, 2026 | 801.65M |
| September 16, 2026 | 782.56M |
| September 15, 2026 | 765.04M |
| September 14, 2026 | 846.08M |
| September 11, 2026 | 915.55M |
| September 10, 2026 | 926.19M |
| September 09, 2026 | 939.95M |
| September 08, 2026 | 953.09M |
| September 04, 2026 | 947.46M |
| September 03, 2026 | 940.58M |
| September 02, 2026 | 971.87M |
| September 01, 2026 | 947.46M |
| August 31, 2026 | 944.33M |
| August 28, 2026 | 945.59M |
| August 27, 2026 | 954.35M |
| August 26, 2026 | 975.62M |
| August 25, 2026 | 981.26M |
| August 24, 2026 | 953.09M |
| August 21, 2026 | 938.08M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Palvella Therapeutics, Inc. | 2.104B |
| Agenus, Inc. | 291.49M |
| Amgen, Inc. | 251.93B |
| Anika Therapeutics, Inc. | 280.37M |
| BioCryst Pharmaceuticals, Inc. | 2.162B |
Market Cap Related Metrics
| PEG Ratio | -1.640 |
| Price to Book Value | 3.311 |
| Price | 10.68 |
| Earnings Yield | -11.05% |
| PEGY Ratio | -1.640 |